Carbamazepine and oxcarbazepine: results and prospects for use in epileptology
- Authors: Poverennova IE1, Yakunina AV1, Kalinin VA1, Savel'eva NN1, Jakunina I.A.1, Kalinin VA1, Saveljeva NN1
-
Affiliations:
- Issue: No 7 (2009)
- Pages: 47-50
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/276820
- ID: 276820
Cite item
Full Text
Abstract
Keywords
About the authors
I E Poverennova
A V Yakunina
V A Kalinin
N N Savel'eva
IE AV Jakunina
V A Kalinin
N N Saveljeva
References
- Белоусов Ю.Б., Белоусов Д.Ю., Чикина Е.С. и др. Исследование медико-социальных проблем эпилепсии в России // Качественная клиническая практика. 2004. № 4. С. 78-79.
- Вейн А.М., Воробьева О.В. Оптимизация тактики терапии симптоматических парциальных эпилепсий с использованием ретардной формы карбамазепина. В кн.: EPI'2000 II Восточноевропейская конференция "Эпилепсия и клиническая нейрофизиология", Крым, Гурзуф. 2000. С. 193-194.
- Гехт А.Б., Мильчакова Л.Е., Чурилин Ю.Ю. и др. Эпидемиология эпилепсии в России // Журнал неврологии и психиатрии. 2006. Т. 106. № 1. С. 3-7.
- Вольф К. Медикаментозное лечение эпилепсии / В кн.: Диагностика и лечение эпилепсий у детей. М., 1997. С. 581-531.
- Зенков Л.Р. Фармакологическое лечение эпилепсии // РМЖ. 2000. Т. 8. № 10. С. 411-417.
- Зенков Л.Р. Роль окскарбазепина в терапии эпилепсии // Consilium medicum. 2005. Т. 7. № 8. С. 710-714.
- Мухин К.Ю., Петрухин А.С. Эпилептические синдромы. Диагностика и стандарты терапии. М., 2005. 143 с.
- "Розничный аудит ГЛС в РФ®" и "Анализ госпитальных закупок ГЛС в РФ®". - www.RMBC.ru, 2004.
- Albani F, Grassi B, Ferrara R, et al. Immediate (overnight) switching from carbamazepine monotherapy is equivalent to a progressive switch. Seizure 2004;13:254-63.
- Bang LM, Goa KL. Oxcarbazepine. A review of its use in childern with epilepsy. Pediatr Drugs 2003;5:557-73.
- Bang LM, Goa KL. Spotlight on oxcarbazepine in epilepsy. CNS Drugs 2004;18:57-61.
- Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000;54:2245-51.
- Brodie MJ, Dicher MA. Antiepileptic drugs. N Engl J Med 1996;334:168-75.
- Clemens B, Menes A, Nagy Z. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol Scand 2004;109:324-29.
- French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-60.
- French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:410-23.
- Heller AJ, Chesterman P, Elwes RDC, et al. Phenobarbitone, phenitoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomized comparative monоtherapy trial. J Neurology Neurosurg Psychiatr 1995;58:44-50.
- Homberg V, Kowalik A, Schulze-Bonhage A. Ad hoc change from carbamazepine to oxcarbazepine - effectiveness and tolerance. A retrospective analysis. Nervenarzt 2001;72:918-23.
- Oxcarbazepine: new preparation. An alternative to carbamazepine in partial epilepsy. Prescrire Int 2001;10:170-74.
- Ryan SW, Forsyth I, Hartley R, et al. Slow release carbamazepine in treatment of poorly controlled seizures. Arch Dis Child 1990;65:930-35.
- Sachdeo R, Beydoun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001;57:864-71.
- Sallas WM, Milosavljev S, D'souza J, et al. Pharmacokinetic drug interactions in children taking oxcarbazepine. Clin Pharmacol Ther 2003;74:138-49.
- Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999;52:732-37.
- Vazquez B. Monotherapy in Epilepsy. Role of the Newer Antiepileptic Drugs. Arch Neurol 2004;61:1361-65.
- Wellington K, Goa KL. Oxcarbazepine: an update of its efficay in the management of epilepsy. CNS Drugs 2001;15:137-63.
- Wolf P. Determinants of outcome in childhood epilepsy. Acta Neurol Scand 2005;112(Suppl. 182):5-8